[1]
Dutt, V.; Thakur, S.; Dhar, V.J.; Sharma, A. The genus Gelsemium: An update. Pharmacogn. Rev., 2010, 4, 185-194.
[2]
Jin, G.L.; Su, Y.P.; Liu, M.; Xu, Y.; Yang, J.; Liao, K.J.; Yu, C.X. Medicinal plants of the genus Gelsemium (Gelsemiaceae, Gentianales)- a review of their phytochemistry, pharmacology, toxicology and traditional use. J. Ethnopharmacol., 2014, 152, 33-52.
[3]
Dutt, V.; Dhar, V.J.; Sharma, A. Antianxiety activity of Gelsemium sempervirens. Pharm. Biol., 2010, 48, 1091-1096.
[4]
Magnani, P.; Conforti, A.; Zanolin, E.; Marzotto, M.; Bellavite, P. Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice. Psychopharmacology (Berl.), 2010, 210, 533-545.
[5]
Ling, Q.; Liu, M.; Wu, M.X.; Xu, Y.; Yang, J.; Huang, H.H.; Yu, C.X. Anti-allodynic and neuroprotective effects of koumine, a Benth alkaloid, in a rat model of diabetic neuropathy. Biol. Pharm. Bull., 2014, 37, 858-864.
[6]
Lu, J.M.; Qi, Q.Z.; Liu, G.L.; Shen, Z.Y. KC, T. Effect of Gelsemium elegans Benth. injection on proliferation of tumor cells. Chin. J. Cancer, 1990, 9, 472-477.
[7]
Zhang, X.; Chen, Y.; Gao, B.; Luo, D.; Wen, Y.; Ma, X. Apoptotic effect of koumine on human breast cancer cells and the mechanism involved. Cell Biochem. Biophys., 2015, 72, 411-416.
[8]
Yuan, Z.; Matias, F.B.; Wu, J.; Liang, Z.; Sun, Z. Koumine attenuates lipopolysaccaride-stimulated inflammation in RAW264.7 Macrophages, coincidentally associated with inhibition of NF-kappaB, ERK and p38 pathways. Int. J. Mol. Sci., 2016, 17, 430.
[9]
Yuan, Z.H.; Liang, Z.E.; Wu, J.; Yi, J.E.; Chen, X.J.; Sun, Z.L. A potential mechanism for the anti-apoptotic property of koumine involving mitochondrial pathway in LPS-mediated RAW 264.7 Macrophages. Molecules, 2016, 21, 1317.
[10]
Qiu, H.Q.; Xu, Y.; Jin, G.L.; Yang, J.; Liu, M.; Li, S.P.; Yu, C.X. Koumine enhances spinal cord 3alpha-hydroxysteroid oxidoreductase expression and activity in a rat model of neuropathic pain. Mol. Pain, 2015, 11, 46.
[11]
Yang, J.; Cai, H.D.; Zeng, Y.L.; Chen, Z.H.; Fang, M.H.; Su, Y.P.; Huang, H.H.; Xu, Y.; Yu, C.X. Effects of koumine on adjuvant-and collagen-induced arthritis in rats. J. Nat. Prod., 2016, 79, 2635-2643.
[12]
Jin, G.L.; Yue, R.C.; He, S.D.; Hong, L.M.; Xu, Y.; Yu, C.X. Koumine decreases astrocyte-mediated neuroinflammation and enhances autophagy, contributing to neuropathic pain from chronic constriction injury in rats. Front. Pharmacol., 2018, 9, 989.
[13]
Jin, G.L.; Yang, J.; Chen, W.Q.; Wang, J.; Qiu, H.Q.; Xu, Y.; Yu, C.X. The analgesic effect and possible mechanisms by which koumine alters type II collagen-induced arthritis in rats. J. Nat. Med., 2018, 73, 217-225.
[14]
Zhou, Z.; Wu, L.; Zhong, Y.; Fang, X.; Liu, Y.; Chen, H.; Zhang, W. Gelsemium elegans poisoning: a case with 8 months of follow-up and review of the literature. Front. Neurol., 2017, 8, 204.
[15]
Xiang, H.; Zhou, Y.J.; Huang, P.L.; Yu, C.N.; Liu, J.; Liu, L.Y.; He, P. Lethal poisoning with Gelsemium elegans in Guizhou, China. Public Health, 2016, 136, 185-187.
[16]
Chen, J.Z.; Li, Y.; Xiao, J.P.; Wu, S.S.; Song, H.W. Development of a sensitive and rapid UPLC-MS/MS method for the determination of koumine in rat plasma: Application to a pharmacokinetic study. Biomed. Chromatogr., 2013, 27, 736-740.
[17]
Zhang, S.; Hu, S.; Yang, X.; Shen, J.; Zheng, X.; Huang, K.; Xiang, Z. Development of a liquid chromatography with mass spectrometry method for the determination of gelsemine in rat plasma and tissue: Application to a pharmacokinetic and tissue distribution study. J. Sep. Sci., 2015, 38, 936-942.
[18]
Ji, S.J.; Liu, W. Simultaneous quantitative analysis of koumine, gelsemine and gelsenicine in biological samples. Fa Yi Xue Za Zhi, 2017, 33, 141-147.
[19]
Yang, K.; Long, X.M.; Liu, Y.C.; Chen, F.H.; Liu, X.F.; Sun, Z.L.; Liu, Z.Y. Development and in-house validation of a sensitive LC-MS/MS method for simultaneous quantification of gelsemine, koumine and humantenmine in porcine plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2018, 1076, 54-60.
[20]
Wang, L.; Wen, Y.; Meng, F. Simultaneous determination of gelsemine and koumine in rat plasma by UPLC-MS/MS and application to pharmacokinetic study after oral administration of Gelsemium elegans Benth extract. Biomed. Chromatogr., 2018, 32e4201
[21]
Liu, Y.C.; Lin, L.; Cheng, P.; Sun, Z.L.; Wu, Y.; Liu, Z.Y. Fingerprint analysis of Gelsemium elegans by HPLC followed by the targeted identification of chemical constituents using HPLC coupled with quadrupole-time-of-flight mass spectrometry. Fitoterapia, 2017, 121, 94-105.
[22]
Lai, C.K.; Chan, Y.W. Confirmation of Gelsemium poisoning by targeted analysis of toxic Gelsemium alkaloids in urine. J. Anal. Toxicol., 2009, 33, 56-61.
[23]
Su, Y.P.; Shen, J.; Xu, Y.; Zheng, M.; Yu, C.X. Preparative separation of alkaloids from Gelsemium elegans Benth. using pH-zone-refining counter-current chromatography. J. Chromatogr. A, 2011, 1218, 3695-3698.
[24]
Rujjanawate, C.; Kanjanapothi, D.; Panthong, A. Pharmacological effect and toxicity of alkaloids from Gelsemium elegans Benth. J. Ethnopharmacol., 2003, 89, 91-95.
[25]
Xu, Y.; Qiu, H.Q.; Shen, J.; Zhuang, W.X.; Zhuang, J.Q.; Zheng, G.Y. al., e. No morphine-like drug dependence potential of koumine. J. Fujian. Med. Univ., 2013, 47, 210-213.
[26]
Chen, S.S.; Chen, Y.H.; Xu, Z.Q. Clinical characteritics of Gelsemium poisoning and its treament. Chin. Crit. Care Med., 2006, 26, 298-300.
[27]
Xie, L.J.; Han, X.F. Mechanism, clinical characteristics and management of Gelsemium elegans poisoning. J. Adv. Drug. Effect., 2006, 8, 202-204.
[28]
Pan, G.Y. The rescue of eight patients with Gelsemism poisoning. J. Chin. Pharm., 2008, 17, 56-57.
